share_log

Merck & Co | 11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)

Merck & Co | 11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)

默沙東 | 11-K:員工持股年度報告
美股sec公告 ·  06/26 01:40
牛牛AI助理已提取核心訊息
Merck & Co., Inc. (Merck) has filed its Form 11-K annual report for the fiscal year ended December 31, 2023, with the United States Securities and Exchange Commission. The report details the financial performance of the MSD Employee Stock Purchase and Savings Plan, which is designed to facilitate employee investment in Merck stock and savings for the future. The independent audit, conducted by PricewaterhouseCoopers LLP, concluded that the financial statements present fairly the net assets available for benefits as of December 31, 2023, and the changes in net assets for the year in accordance with U.S. accounting principles. The Plan's net assets available for benefits increased from $463.376 million in 2022 to $498.619 million in 2023. The Plan allows eligible employees to contribute a portion of their...Show More
Merck & Co., Inc. (Merck) has filed its Form 11-K annual report for the fiscal year ended December 31, 2023, with the United States Securities and Exchange Commission. The report details the financial performance of the MSD Employee Stock Purchase and Savings Plan, which is designed to facilitate employee investment in Merck stock and savings for the future. The independent audit, conducted by PricewaterhouseCoopers LLP, concluded that the financial statements present fairly the net assets available for benefits as of December 31, 2023, and the changes in net assets for the year in accordance with U.S. accounting principles. The Plan's net assets available for benefits increased from $463.376 million in 2022 to $498.619 million in 2023. The Plan allows eligible employees to contribute a portion of their base pay to invest in various options, including Merck common stock, with the company providing matching contributions. The Plan is subject to ERISA and is administered by committees appointed by Merck's CEO and Board of Directors. The report also includes a summary of the Plan's investment strategies, contributions, participant accounts, and related-party transactions, confirming that the Plan operates in compliance with the Internal Revenue Code and ERISA.
默沙東公司(Merck)已向美國證券交易所提交其截至2023年12月31日財政年度的11-K表格年度報告。該報告詳細描述了MSD員工股票購買和儲蓄計劃的財務表現,該計劃旨在便於員工投資默沙東股票和爲未來儲蓄。由普華永道審計的獨立審計認爲,財務報表以美國會計準則的要求充分準確地呈現了2023年12月31日可供福利使用的淨資產以及該年淨資產的變化。計劃的可供福利淨資產從2022年的463.376百萬美元增長到2023年的498.619百萬美元。該計劃允許符合資格的員工貢獻部分工資以投資於各種期權,包括默沙東普通股,公司提供相應的捐贈。該計劃受ERISA法案的規定,並由默沙東公司的首席執行官和董事會委員會管理。報告還包括計劃的投資策略、出資、參與者帳户和相關方交易摘要,確認該計劃符合美國內部收入法典和ERISA的規定。
默沙東公司(Merck)已向美國證券交易所提交其截至2023年12月31日財政年度的11-K表格年度報告。該報告詳細描述了MSD員工股票購買和儲蓄計劃的財務表現,該計劃旨在便於員工投資默沙東股票和爲未來儲蓄。由普華永道審計的獨立審計認爲,財務報表以美國會計準則的要求充分準確地呈現了2023年12月31日可供福利使用的淨資產以及該年淨資產的變化。計劃的可供福利淨資產從2022年的463.376百萬美元增長到2023年的498.619百萬美元。該計劃允許符合資格的員工貢獻部分工資以投資於各種期權,包括默沙東普通股,公司提供相應的捐贈。該計劃受ERISA法案的規定,並由默沙東公司的首席執行官和董事會委員會管理。報告還包括計劃的投資策略、出資、參與者帳户和相關方交易摘要,確認該計劃符合美國內部收入法典和ERISA的規定。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。